These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 38566120)
1. Tumor associated microglia/macrophages utilize GPNMB to promote tumor growth and alter immune cell infiltration in glioma. Yalcin F; Haneke H; Efe IE; Kuhrt LD; Motta E; Nickl B; Flüh C; Synowitz M; Dzaye O; Bader M; Kettenmann H Acta Neuropathol Commun; 2024 Apr; 12(1):50. PubMed ID: 38566120 [TBL] [Abstract][Full Text] [Related]
2. Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1. Szulzewsky F; Pelz A; Feng X; Synowitz M; Markovic D; Langmann T; Holtman IR; Wang X; Eggen BJ; Boddeke HW; Hambardzumyan D; Wolf SA; Kettenmann H PLoS One; 2015; 10(2):e0116644. PubMed ID: 25658639 [TBL] [Abstract][Full Text] [Related]
3. Deletion of the RNA regulator HuR in tumor-associated microglia and macrophages stimulates anti-tumor immunity and attenuates glioma growth. Wang J; Leavenworth JW; Hjelmeland AB; Smith R; Patel N; Borg B; Si Y; King PH Glia; 2019 Dec; 67(12):2424-2439. PubMed ID: 31400163 [TBL] [Abstract][Full Text] [Related]
4. Glycoprotein nonmetastatic melanoma protein B (GPNMB) promotes the progression of brain glioblastoma via Na Ono Y; Chiba S; Yano H; Nakayama N; Saio M; Tsuruma K; Shimazawa M; Iwama T; Hara H Biochem Biophys Res Commun; 2016 Dec; 481(1-2):7-12. PubMed ID: 27836549 [TBL] [Abstract][Full Text] [Related]
5. Tumour-associated microglia/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumour subtype. Sørensen MD; Dahlrot RH; Boldt HB; Hansen S; Kristensen BW Neuropathol Appl Neurobiol; 2018 Feb; 44(2):185-206. PubMed ID: 28767130 [TBL] [Abstract][Full Text] [Related]
6. Programmed Cell Death 10 Mediated CXCL2-CXCR2 Signaling in Regulating Tumor-Associated Microglia/Macrophages Recruitment in Glioblastoma. Zhang Q; Wang J; Yao X; Wu S; Tian W; Gan C; Wan X; You C; Hu F; Zhang S; Zhang H; Zhao K; Shu K; Lei T Front Immunol; 2021; 12():637053. PubMed ID: 34108959 [TBL] [Abstract][Full Text] [Related]
7. Activation of CECR1 in M2-like TAMs promotes paracrine stimulation-mediated glial tumor progression. Zhu C; Mustafa D; Zheng PP; van der Weiden M; Sacchetti A; Brandt M; Chrifi I; Tempel D; Leenen PJM; Duncker DJ; Cheng C; Kros JM Neuro Oncol; 2017 May; 19(5):648-659. PubMed ID: 28453746 [TBL] [Abstract][Full Text] [Related]
8. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response. Sielska M; Przanowski P; Wylot B; Gabrusiewicz K; Maleszewska M; Kijewska M; Zawadzka M; Kucharska J; Vinnakota K; Kettenmann H; Kotulska K; Grajkowska W; Kaminska B J Pathol; 2013 Jul; 230(3):310-21. PubMed ID: 23520016 [TBL] [Abstract][Full Text] [Related]
9. SorLA restricts TNFα release from microglia to shape a glioma-supportive brain microenvironment. Kaminska P; Ovesen PL; Jakiel M; Obrebski T; Schmidt V; Draminski M; Bilska AG; Bieniek M; Anink J; Paterczyk B; Jensen AMG; Piatek S; Andersen OM; Aronica E; Willnow TE; Kaminska B; Dabrowski MJ; Malik AR EMBO Rep; 2024 May; 25(5):2278-2305. PubMed ID: 38499808 [TBL] [Abstract][Full Text] [Related]
10. Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma. Pachocki CJ; Hol EM J Neuroinflammation; 2022 Nov; 19(1):276. PubMed ID: 36403059 [TBL] [Abstract][Full Text] [Related]
11. Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas. Zeiner PS; Preusse C; Golebiewska A; Zinke J; Iriondo A; Muller A; Kaoma T; Filipski K; Müller-Eschner M; Bernatz S; Blank AE; Baumgarten P; Ilina E; Grote A; Hansmann ML; Verhoff MA; Franz K; Feuerhake F; Steinbach JP; Wischhusen J; Stenzel W; Niclou SP; Harter PN; Mittelbronn M Brain Pathol; 2019 Jul; 29(4):513-529. PubMed ID: 30506802 [TBL] [Abstract][Full Text] [Related]
12. SMAC mimetic drives microglia phenotype and glioblastoma immune microenvironment. Snacel-Fazy E; Soubéran A; Grange M; Joseph K; Colin C; Morando P; Luche H; Pagano A; Brustlein S; Debarbieux F; Toutain S; Siret C; van de Pavert SA; Rougon G; Figarella-Branger D; Ravi VM; Tabouret E; Tchoghandjian A Cell Death Dis; 2024 Sep; 15(9):676. PubMed ID: 39278921 [TBL] [Abstract][Full Text] [Related]
16. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment. Müller S; Kohanbash G; Liu SJ; Alvarado B; Carrera D; Bhaduri A; Watchmaker PB; Yagnik G; Di Lullo E; Malatesta M; Amankulor NM; Kriegstein AR; Lim DA; Aghi M; Okada H; Diaz A Genome Biol; 2017 Dec; 18(1):234. PubMed ID: 29262845 [TBL] [Abstract][Full Text] [Related]
17. CXCL16/CXCR6 Axis Drives Microglia/Macrophages Phenotype in Physiological Conditions and Plays a Crucial Role in Glioma. Lepore F; D'Alessandro G; Antonangeli F; Santoro A; Esposito V; Limatola C; Trettel F Front Immunol; 2018; 9():2750. PubMed ID: 30542347 [TBL] [Abstract][Full Text] [Related]